FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine, namely to otolaryngology and immunology, and relates to treatment of allergic rhinitis. For this purpose, a composition containing mometasone furoate and olopatadine hydrochloride is administered to a patient. Said composition is administered nasally in the form of 2 puffs into each nostril 2 times a day. Each puff contains 25 mcg of mometasone furoate and 665 mcg of olopatadine hydrochloride.
EFFECT: introduction of the composition provides an effective treatment of allergic rhinitis due to the synergistic effect of its components.
36 cl, 6 dwg, 6 tbl, 4 ex
Title |
Year |
Author |
Number |
TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN |
2014 |
- Khajratkar Dzhoshi, Neelima
- Kulkarni, Abkhaj
- Val, Dinesh Pradip
- Bkhosli, Vikram Mansingkh
- Agarval, Piyush
- Keokhejn, Patrik
- Tantri, Sudish, K.
- O, Ched
|
RU2799761C2 |
TREATMENT OF ALLERGIC RHINITIS IN PEDIATRIC CATEGORY USING A COMBINATION OF MOMETASONE AND OLOPATADINE |
2019 |
- Kajratkar-Dzhoshi, Neelima
- Kulkarni, Abkhaj
- Vale, Dinesh Pradip
- Bkhosale, Vikram M.
- Agarval, Piyush
- Keokhejn, Patrik
- Tantri, Sudish K.
- O, Ched
|
RU2798030C2 |
COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS |
2013 |
- Ignar Diane Michele
- Levin Daren Scott
|
RU2652352C2 |
STABLE PHARMACEUTICAL COMPOSITION WITH FIXED DOSE, CONTAINING MOMETASONE AND OLOPATADINE |
2014 |
- Dkhuppad Ulkhas
- Katkurvar Ashok
- Gupta Yashvant
- Ankam Radzhesh
- Dkhatrak Chandrakant
|
RU2687551C2 |
THERAPEUTIC AGENT FOR TREATING RHINITIS |
2010 |
|
RU2502519C2 |
NASAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION THEREOF |
2004 |
|
RU2380090C2 |
NASAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION THEREOF |
2004 |
|
RU2373925C2 |
METHODS FOR TREATING NASAL POLYPOSIS BY ADMINISTERING IL-4R ANTAGONIST |
2014 |
- Mannen Leda
- Pirotstsi Dzhanluka
- Rejdin Allen
- Gandkhi Namita A.
- Evans Robert
|
RU2674680C2 |
PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION CONTAINING CORTICOSTEROID AND QUINOLONE OR FUSIDIC ACID |
2012 |
|
RU2614716C2 |
IMPROVEMENT OF NASAL COMPOSITIONS AND METHOD FOR THEIR USE |
2015 |
|
RU2781144C2 |